Chairman & Chief Executive Officer at Panavance Therapeutics Inc.
Greg Bosch is currently the Chairman & Chief Executive Officer at Panavance Therapeutics INC.
Previously, Greg served as the CEO of Geistlich Pharma North America, the leader in regenerative medicine in dental field. Greg was previously President and CEO of PuriCore and held various leadership positions at Baxter International. Greg received his BA in Public Policy from Duke University and his MBA from DePaul University. In 2006, Greg received the Life Sciences CEO of the Year award at the Eastern Technology Council’s Enterprise Awards.